Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform
- 1 June 2008
- Vol. 26 (27-28) , 3395-3403
- https://doi.org/10.1016/j.vaccine.2008.04.052
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Novel Plant Virus-Based Vaccine Induces Protective Cytotoxic T-Lymphocyte-Mediated Antiviral Immunity through Dendritic Cell MaturationJournal of Virology, 2008
- Proteasome-Independent Major Histocompatibility Complex Class I Cross-Presentation Mediated by Papaya Mosaic Virus-Like Particles Leads to Expansion of Specific Human T CellsJournal of Virology, 2007
- Influenza and the challenge for immunologyNature Immunology, 2006
- The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protectionVaccine, 2006
- Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrierJournal of Pharmaceutical Sciences, 2006
- Effect of mutations K97A and E128A on RNA binding and self assembly of papaya mosaic potexvirus coat proteinThe FEBS Journal, 2005
- Use of viral vectors for vaccine production in plantsImmunology & Cell Biology, 2005
- A “universal” human influenza A vaccineVirus Research, 2004
- A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responsesVaccine, 2002
- A NEUROTROPIC STRAIN OF HUMAN INFLUENZA VIRUSThe Lancet, 1939